查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941462

美国外泌体市场规模、份额和趋势分析报告：按产品/服务、应用、工作流程、最终用途和细分市场预测，2026-2033年

U.S. Exosomes Market Size, Share & Trends Analysis Report By Product & Service, By Application, By Workflow, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国外泌体市场概述

据估计，美国外泌体市场在 2025 年的价值为 1.156 亿美元，预计到 2033 年将达到 7.168 亿美元。

预计2026年至2033年，该市场将以25.75%的复合年增长率成长。外泌体应用领域的不断拓展是推动市场成长的主要因素。外泌体分离技术和分析方法的进步也促进了市场成长，而癌症患者数量的增加则是推动市场成长的因素之一。

癌症发生率增加

癌症发生率上升是预测期内推动市场成长的主要因素之一，预计到 2025 年，仅在美国就将新增 200 万例癌症病例。

外泌体作为潜在的生物标记物，在癌症早期检测、疾病进展监测和疗效评估方面备受关注。随着全球癌症发病率的不断上升，对先进诊断工具和标靶治疗的需求日益增长，而基于外泌体的技术发展有望促进这些需求的实现。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数与趋势

  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析

第四章：美国外泌体市场按产品和服务分類的估算和趋势分析

  • 美国外泌体产品与服务仪錶板
  • 依产品/服务分析美国外泌体的变化
  • 试剂盒和试剂
  • 装置
  • 服务

第五章：美国外泌体市场按应用领域分類的趋势分析

  • 美国外泌体市场按应用分類的概览
  • 依应用分析美国外泌体市场波动情况
  • 癌症
  • 神经退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他的

6. 美国外泌体市场依工作流程分類的估算与趋势分析

  • 美国外泌体市场工作流程特定仪表板
  • 依工作流程分析美国外泌体市场差异
  • 分离方法
    • 超速离心
    • 基于微珠的免疫捕获
    • 降水法
    • 过滤
    • 其他的
  • 下游分析
    • 下游分析
    • 利用流式细胞技术进行细胞表面标誌物分析
    • 利用印迹法和ELISA法进行蛋白质分析
    • 利用NGS和PCR进行RNA分析
    • 利用质谱法进行蛋白质体分析
    • 其他的

7. 美国外泌体市场依最终用途分類的估算与趋势分析

  • 美国外泌体市场按最终用途分類的概览
  • 以最终用途分析美国外泌体市场波动
  • 製药和生物技术公司
  • 医院和诊断中心
  • 学术和研究机构

第八章 竞争情势

  • 参与企业
  • 2025年公司市场分析
  • 公司简介
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Hologic Inc.
    • Bio-Techne
    • RoosterBio, Inc
    • Fujifilm Holdings Corporation
    • Lonza
    • Miltenyi Biotec
    • QIAGEN
    • CellBio Scientific
Product Code: GVR-4-68040-242-7

U.S. Exosomes Market Summary

The U.S. exosomes market size was estimated at USD 115.6 million in 2025 and is projected to reach USD 716.8 million by 2033, growing at a CAGR of 25.75% from 2026 to 2033. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contributing to market growth and are fueled by the increasing prevalence of cancer.

Increasing Prevalence of Cancer

The increasing prevalence of cancer is one of the key factors contributing to market growth over the forecast period. In 2025, an estimated over 2 million new cancer cases were diagnosed in the U.S. alone.

Exosomes have gained attention for their potential as biomarkers for early cancer detection, monitoring disease progression, and assessing therapeutic responses. With the global incidence of cancer on the rise, there is an increasing need for advanced diagnostic tools and targeted treatments, the development of which can be facilitated by exosome-based technologies.

U.S. Exosomes Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. exosomes market based on product & service, application, workflow, and end use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & reagents
  • Instruments
  • Services
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Isolation Methods
    • Ultracentrifugation
    • Immunocapture on beads
    • Precipitation
    • Filtration
    • Others
  • Downstream Analysis
    • Cell surface marker analysis using flow cytometry
    • Protein Analysis using blotting & ELISA
    • RNA analysis with NGS & PCR
    • Proteomic analysis using mass spectroscopy
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Application Segment
    • 1.1.2. Product & Service Segment
    • 1.1.3. Workflow Segment
    • 1.1.4. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
      • 3.2.1.2. Advanced applications of exosomes
      • 3.2.1.3. Growth in strategic initiatives for exosome-based therapies
      • 3.2.1.4. Increasing prevalence of cancer
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations pertaining to approval
      • 3.2.2.2. Challenges associated with the implementation of exosome-based therapies
      • 3.2.2.3. Reduction in funding for biomedical research
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Exosomes Market Product & Service Estimates & Trend Analysis

  • 4.1. U.S. Exosomes Product & Service Dashboard
  • 4.2. U.S. Exosomes Product & Service Movement Analysis
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Exosomes Market Application & Trend Analysis

  • 5.1. U.S. Exosomes Market Application Dashboard
  • 5.2. U.S. Exosomes Market Application Movement Analysis
  • 5.3. Cancer
    • 5.3.1. Cancer Market, 2021 - 2033 (USD Million)
  • 5.4. Neurodegenerative Diseases
    • 5.4.1. Neurodegenerative Diseases Market, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis

  • 6.1. U.S. Exosomes Market Workflow Dashboard
  • 6.2. U.S. Exosomes Market Workflow Movement Analysis
  • 6.3. Isolation Methods
    • 6.3.1. Isolation Methods Market, 2021 - 2033 (USD Million)
    • 6.3.2. Ultracentrifugation
      • 6.3.2.1. Ultracentrifugation Market, 2021 - 2033 (USD Million)
    • 6.3.3. Immunocapture On Beads
      • 6.3.3.1. Immunocapture On Beads Market, 2021 - 2033 (USD Million)
    • 6.3.4. Precipitation
      • 6.3.4.1. Precipitation Market, 2021 - 2033 (USD Million)
    • 6.3.5. Filtration
      • 6.3.5.1. Filtration Market, 2021 - 2033 (USD Million)
    • 6.3.6. Others
      • 6.3.6.1. Other Isolation Methods Market, 2021 - 2033 (USD Million)
  • 6.4. Downstream Analysis
    • 6.4.1. Downstream Analysis Market, 2021 - 2033 (USD Million)
    • 6.4.2. Cell Surface Marker Analysis Using Flow Cytometry
      • 6.4.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2021 - 2033 (USD Million)
    • 6.4.3. Protein Analysis Using Blotting & ELISA
      • 6.4.3.1. Protein Analysis Using Blotting & ELISA Market, 2021 - 2033 (USD Million)
    • 6.4.4. RNA Analysis With NGS & PCR
      • 6.4.4.1. RNA Analysis With NGS & PCR Market, 2021 - 2033 (USD Million)
    • 6.4.5. Proteomic Analysis Using Mass Spectrometry
      • 6.4.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2021 - 2033 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Other Downstream Analysis Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Exosomes Market End Use Estimates & Trend Analysis

  • 7.1. U.S. Exosomes Market End Use Dashboard
  • 7.2. U.S. Exosomes Market End Use Movement Analysis
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.4. Hospitals & Diagnostics Centers
    • 7.4.1. Hospitals & Diagnostics Centers Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2025
  • 8.3. Company Profiles
    • 8.3.1. Danaher
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Thermo Fisher Scientific, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Hologic Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Bio-Techne
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. RoosterBio, Inc
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Fujifilm Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Lonza
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Miltenyi Biotec
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CellBio Scientific
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. U.S. Exosomes Market, By Product, 2021 - 2033 (USD Million)
  • Table 3. U.S. Exosomes Market, By Application, 2021 - 2033 (USD Million)
  • Table 4. U.S. Exosomes Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 5. U.S. Exosomes Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 U.S. Exosomes Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 U.S. Exosomes Market: Product & service outlook and key takeaways
  • Fig. 13 U.S. Exosomes Market: Product & service movement analysis & market share 2025 & 2033
  • Fig. 14 Kits & reagents market, 2021 - 2033 (USD Million)
  • Fig. 15 Instruments market, 2021 - 2033 (USD Million)
  • Fig. 16 Services market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Exosomes Market: Application outlook and key takeaways
  • Fig. 18 U.S. Exosomes Market: Application movement analysis & market share
  • Fig. 19 Isolation methods market, 2021 - 2033 (USD Million)
  • Fig. 20 Ultracentrifugation market, 2021 - 2033 (USD Million)
  • Fig. 21 Immunocapture on beads market, 2021 - 2033 (USD Million)
  • Fig. 22 Precipitation market, 2021 - 2033 (USD Million)
  • Fig. 23 Filtration market, 2021 - 2033 (USD Million)
  • Fig. 24 Other isolation methods market, 2021 - 2033 (USD Million)
  • Fig. 25 Downstream analysis market, 2021 - 2033 (USD Million)
  • Fig. 26 Cell surface marker analysis using flow cytometry market, 2021 - 2033 (USD Million)
  • Fig. 27 Protein analysis using blotting & ELISA market, 2021 - 2033 (USD Million)
  • Fig. 28 RNA analysis with NGS & PCR market, 2021 - 2033 (USD Million)
  • Fig. 29 Proteomic analysis using mass spectroscopy market, 2021 - 2033 (USD Million)
  • Fig. 30 Other downstream analysis market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Exosomes Market: Application outlook and key takeaways
  • Fig. 32 U.S. Exosomes Market: Application movement analysis & market share
  • Fig. 33 Cancer market, 2021 - 2033 (USD Million)
  • Fig. 34 Neurodegenerative diseases market, 2021 - 2033 (USD Million)
  • Fig. 35 Cardiovascular diseases market, 2021 - 2033 (USD Million)
  • Fig. 36 Infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 37 Other applications market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Exosomes Market: End use outlook and key takeaways
  • Fig. 39 U.S. Exosomes Market: End use movement analysis & market share
  • Fig. 40 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 41 Hospitals & diagnostics centers market estimates and forecast, 2021 - 2033
  • Fig. 42 Academic and research institutes market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033